New Guideline 5 Electrophysiological Recording and Stimulation System

Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients affected by Parkinson’s disease. 

BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food and Drug Administration (FDA) for the Guideline 4000 5.0™ electrophysiological recording and stimulation system.

BOWDOIN, ME – FHC, Inc., a global manufacturer of products for the neuroscience industry, has announced the internal promotion of two employees.